Aadi Bioscience, Inc. - AADI Net Sales Margin

Brandmark of Aadi Bioscience Inc (AADI)

Aadi Bioscience maintains a strong market position as a precision oncology innovator, which is further supported by its sales return ratio. The current value of this parameter is -246.10. This trend is driven by the commercial success of Fyarro and M&A potential, although a narrow patient base with rare tumors limits operational growth, creating a niche cash flow effect.

Aadi Bioscience Inc (AADI) - Net Return on Sales from 07/04/2022 to 03/19/2025

aadibio.com - analytical breakdowns and key metrics (AADI)

- share price and consensus valuation forecast:
Summary company analytics:Aadi Bioscience Inc - AADI
Finished products of Aadi Bioscience

Sales margins reflect the efficiency of converting revenue into net profit. By analyzing the final sales margin, an investor can determine the portion of income remaining after all deductions. This metric is calculated as the ratio of net result to total sales volume. For Aadi Bioscience (AADI), this is critical due to the complete outsourcing of development. Dependence on external vendors makes profitability sensitive to any changes in the cost of contract services.